Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

925
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
925
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

46.1K
VSEPR Theory for Determination of Electron Pair Geometries
46.1K
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Prediction Intervals01:03

Prediction Intervals

3.4K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.4K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.8K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.4K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Patients for a Community Health Worker Program Using an Artificial Intelligence Algorithm.

Learning health systems·2026
Same author

Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer risk.

Breast cancer research : BCR·2026
Same author

The Human Male Mammary Gland has Similar Epithelial Populations to Female but Distinct Composition and Transcriptional Properties.

bioRxiv : the preprint server for biology·2026
Same author

Epidermal Growth Factor Receptor/KIT-Linked Proliferative Bias in Normal Breast Lobules from Matched Non-Hispanic Black and White Women Is Rapidly Reversible by Receptor Tyrosine Kinase Inhibition.

The American journal of pathology·2026
Same author

Tissue Microarray-Based Digital Spatial Profiling of Benign Breast Lobules and Breast Cancers: Feasibility, Biological Coherence, and Cross-Platform Benchmarks.

Cancers·2025
Same author

Accurate and Scalable Classification of Colonoscopy Neoplasia Using Machine Learning and Natural Language Processing.

Clinical and translational gastroenterology·2025
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Metabolic Modulation in Cancer Care: The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Related Experiment Video

Updated: Feb 11, 2026

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

30.3K

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.

Amy C Degnim1, Stacey J Winham1, Ryan D Frank1

  • 1Amy C. Degnim, Stacey J. Winham, Ryan D. Frank, Robert A. Vierkant, Marlene H. Frost, Tanya L. Hoskin, Celine M. Vachon, Karthik Ghosh, Tina J. Hieken, Jodi M. Carter, Lori A. Denison, Brendan Broderick, Lynn C. Hartmann, and Daniel W. Visscher, Mayo Clinic, Rochester, MN; V. Shane Pankratz, University of New Mexico Health Sciences Center, Albuquerque, NM; William D. Dupont, Vanderbilt University, Nashville, TN; and Derek C. Radisky, Mayo Clinic, Jacksonville, FL.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|April 21, 2018
PubMed
Summary
This summary is machine-generated.

A new breast cancer (BC) risk model, AH-BC, was developed for women with atypical hyperplasia (AH). This model accurately predicts BC risk, improving upon existing methods for this high-risk group.

More Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.9K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.1K

Related Experiment Videos

Last Updated: Feb 11, 2026

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

30.3K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.9K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.1K

Area of Science:

  • Oncology
  • Biostatistics
  • Pathology

Background:

  • Women with atypical hyperplasia (AH) on breast biopsy face an elevated risk of breast cancer (BC).
  • Current risk prediction models lack precision for individualizing BC risk in this specific high-risk population.
  • Accurate risk stratification is crucial for guiding surveillance and management strategies.

Purpose of the Study:

  • To develop and validate a novel breast cancer risk prediction model specifically for women diagnosed with atypical hyperplasia (AH).
  • To designate this new model as the AH-BC risk prediction tool.
  • To improve individualized risk assessment for women with AH.

Main Methods:

  • Utilized retrospective cohorts from Rochester, MN, and Nashville, TN, comprising women aged 18-85 with pathologically confirmed benign AH.
  • Employed L1-penalized Cox proportional hazards regression to identify key clinical and histologic risk factors.
  • Applied a Fine and Gray regression model to estimate BC risk, accounting for death as a competing risk, and assessed model performance using discrimination and calibration metrics.

Main Results:

  • The model-building set included 699 women with AH (142 BC events), and the external validation set comprised 461 women (114 BC events).
  • The final AH-BC model incorporates age at biopsy, age at biopsy squared, and the number of AH foci.
  • The AH-BC model demonstrated good discrimination (0.63) and calibration (0.87) at 10 years in the development set, with acceptable performance (0.59 discrimination, 0.91 calibration) in the external validation set.

Conclusions:

  • A new, validated model (AH-BC) has been developed to refine breast cancer risk prediction for women with atypical hyperplasia.
  • The AH-BC model exhibits robust discrimination and calibration, proving effective in an external validation cohort.
  • This tool offers a more precise method for assessing individual breast cancer risk in women with AH, aiding clinical decision-making.